XBiotech Inc (NASDAQ: XBIT) stock closed at $6.79 on 9/20/24 after a major decline of -14.6%. Moreover, trading volume in this decline was exceptionally high at 472% of normal. The stock has been exceptionally strong relative to the market over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
XBiotech has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. XBiotech has a poor Appreciation Score of 26 but a good Power Rating of 76, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment